Search results for "Keeping tabs"


 
Results 1 - 10 of about 136 for "Keeping tabs".
Sort by: Relevance | Newest | Oldest

Spotlight on the 2024 Standards of Care

The American Diabetes Association made its annual updates to the Standards of Care in Diabetes, addressing newer drug classes and growing evidence for bariatric surgery and heart failure screening, among many other changes.
https://diabetes.acponline.org/archives/2024/01/12/5.htm
12 Jan 2024

Spotlight on comparisons within diabetes drug classes

One review found tirzepatide to have more effect on glycemic outcomes than other glucagon-like peptide-1 receptor agonists, while another showed several sodium-glucose cotransporter-2 inhibitors to have similar effects on cardiovascular outcomes.
https://diabetes.acponline.org/archives/2024/02/09/5.htm
9 Feb 2024

Spotlight on lifestyle factors and diabetes outcomes

In patients with type 2 diabetes, a healthier lifestyle was associated with reduced risk of macrovascular and microvascular disease, one study found, while another showed the same for diabetic kidney disease and a third highlighted the benefits of leisure-time physical activity.
https://diabetes.acponline.org/archives/2023/09/08/5.htm
8 Sep 2023

Spotlight on technology for pregnant diabetes patients

Studies of continuous glucose monitoring in pregnant patients with type 1 or 2 diabetes highlighted the effects of time in range on neonatal outcomes, while two others tested automated insulin delivery during pregnancy in type 1 diabetes patients.
https://diabetes.acponline.org/archives/2023/10/13/5.htm
13 Oct 2023

Spotlight on glycemia and dementia

One study found reduced rates of dementia in patients with type 2 diabetes who took metformin, while another showed that impaired fasting glucose posed a cognitive risk, and a review compared diabetes drug classes for their effects on dementia risk.
https://diabetes.acponline.org/archives/2023/12/08/5.htm
8 Dec 2023

Spotlight on novel therapies for type 1 diabetes

Manufacturer trials reported the effects of weekly insulin and teplizumab in patients with type 1 diabetes, while recent reviews looked at preventing beta-cell loss with various therapeutics and using drugs approved for type 2 diabetes to combat chronic kidney disease in type 1.
https://diabetes.acponline.org/archives/2023/11/10/5.htm
10 Nov 2023

Spotlight on racial differences in risk assessment

A scientific statement from the American Heart Association offered guidance on the epidemiology of diabetes among Asian American people, while an analysis of the algorithms for predicting type 2 diabetes found that they make lower estimates of risk in Black patients than White.
https://diabetes.acponline.org/archives/2023/06/09/5.htm
9 Jun 2023

Spotlight on NAFLD

Recent studies looked at the risks associated with nonalcoholic fatty liver disease (NAFLD), also known as metabolic dysfunction-associated steatotic liver disease (MASLD), the effects of diabetes drugs on the condition, and whether machine learning can help identify patients at risk.
https://diabetes.acponline.org/archives/2024/03/08/5.htm
8 Mar 2024

Spotlight on weekly insulins

Pharmaceutical manufacturers recently published studies on investigational basal insulin formulations that could be taken once a week by patients with type 1 or type 2 diabetes.
https://diabetes.acponline.org/archives/2023/05/12/5.htm
12 May 2023

Spotlight on weight loss drugs

The American Society of Anesthesiologists released guidance on preoperative management of glucagon-like peptide-1 receptor agonists, and recent studies looked at the effects of semaglutide, retatrutide, and orforglipron on weight in patients with and without diabetes.
https://diabetes.acponline.org/archives/2023/07/14/5.htm
14 Jul 2023

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next